Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Glioblastoma 45 Glioma 16 Neuroblastoma 15 Brain Neoplasms 14 Astrocytoma 10 Neoplasms 8 Rhabdomyosarcoma 7 Sarcoma, Ewing 6 Recurrence 5 Oligodendroglioma 5 Medulloblastoma 5 Sarcoma 4 Osteosarcoma 4 Melanoma 4 Small Cell Lung Carcinoma 3 Neuroendocrine Tumors 3 Neuroectodermal Tumors, Primitive 3 Lymphoma 3 Gliosarcoma 3 Diffuse Intrinsic Pontine Glioma 3 Wilms Tumor 2 Rhabdoid Tumor 2 Pyloric Stenosis, Hypertrophic 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Ganglioneuroblastoma 2 Fallopian Tube Neoplasms 2 Ependymoma 2 Colorectal Neoplasms 2 Central Nervous System Neoplasms 2

Interventions

cabozantinib 7 pembrolizumab 6 Nivolumab 6 Ipilimumab 5 Axitinib 5 Radiosurgery 3 Blood Specimen Collection 3 zimberelimab 2 lenvatinib 2 Ultrasonography 2 Radiotherapy 2 Biopsy 2 tislelizumab 1 polyethylene glycol 3350 1 pazopanib 1 palbociclib 1 orellanine 1 olaparib 1 gallium Ga 68 dotatate 1 fludarabine 1 cyclopropapyrroloindole 1 brodalumab 1 belzutifan 1 atezolizumab 1 anlotinib 1 adagrasib 1 Watchful Waiting 1 Vincristine 1 Therapeutics 1 Temozolomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Kidney Neoplasms × Temozolomide × Clear all

NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡